As troubling as these statistics may be, public fitness experts warn that autumn and winter may be even worse, the Washington Post reported.
A wave of COVID-19 cases in cold climates can cause a “second wave” of highly feared infections and deaths beginning well before Election Day in November, although scientists peaked at weeks later, the Post reported.
“I have a feeling a wave is coming, and it’s not so much if it happens, but how big it will be,” he told Eili Klein, epidemiologist at Johns Hopkins University School of Medicine in Baltimore.
Still, national numbers have slowly declined as a result of waves in the solar belt in early summer, the Post reported.
A style developed through the University of Washington Institute of Health Assessment and Metrics (IHME) predicts a death toll of 1,907 on Election Day, roughly double the existing figure. December, achieving more than 2,800 deaths consistent with the day.
By the end of the year, more than 410,000 will have died in the maximum likely maximum situation of the model, more than double the existing total.
“I am firmly convinced that we will see different waves of moments, even in the put that ended their first waves. New York, I’m watching you,” said Andrew Noymer, epidemiologist at the University of California, Irvine.
“I hope the autumn waves start in mid-October and get worse as autumn progresses into winter, and will succeed in a crescendo after the election,” he told the newspaper. “Some options will succeed at their peak around Thanksgiving, some options will succeed at their peak around Christmas, others not before January and February. “
Trump’s senior adviser says October vaccine is ‘extremely unlikely’
As Trump’s leadership rushes to produce a COVID-19 vaccine as temporarily as possible, the White House’s leading immunization adviser said it was “extremely unlikely, but not impossible” that a vaccine could be obtained until the end of October.
In statements to national public radio last week, Dr. Moncef Slaoui said the recommendation of the U. S. Centers for Disease Control and PreventionBut it’s not the first time Preparing for a vaccine at the end of October “is the right thing to do” in case a vaccine is in good condition during that time.
“It would be irresponsible not to be in a position if that were the case,” Slaoui said, adding that he had first heard about the new directions of the CDC’s media, the Post reported.
However, Slaoui, Operation Warp Speed’s leading clinical advisor, described getting vaccinated in late October as “a very, very low probability. “
The message contradicted the White House’s positive claims that a vaccine could be in a position to be distributed before the November presidential election. At the Republican National Convention, President Trump announced that a vaccine could be in a position “before the end of the year. “or maybe even before. “
Slaoui showed that the two main candidate vaccines, called vaccine A and B vaccine through the CDC, were being developed through Pfizer and Moderna respectively. He said there is “no intention” to introduce a vaccine before clinical trials are completed. ended until an indefinite protection oversight committee showed the effectiveness of the vaccine, he added.
While expressing doubts about an October calendar, Slaoui believes that “we will have a vaccine before the end of the year and that it will be available in quantities to vaccinate patients, subjects at peak risk. “
At the end of the year, there will be enough doses of vaccine in a position to vaccinate “probably between 20 and 25 million people. “
There will be enough doses to immunize the American population “by mid-2021,” he added.
Antibody suggests lasting immunity to COVID
In a discovery that inspires scientists rushing to expand coronavirus vaccines, a new study in Iceland suggests that immunity to the disease may not be as ephemeral as previously thought.
Among the 30,000 Icelandic citizens tested for COVID-19 antibodies, researchers found that antibodies remained in people’s systems for at least 4 months, according to the study.
Of those who tested positive for coronavirus, 487 had won several antibody tests. In the first two months after a patient’s diagnosis, antibodies can confer higher immunity significantly. Over the next two months, antibody grades remained stable, according to the recently published study. In the New England Journal of Medicine.
In an observation accompanying the exam, scientists at Harvard University and the U. S. National Institutes of HealthBut it’s not the first time They noted that if Icelandic studies focused on a largely homogeneous population, “this test suggests that the host’s immunity to this unpredictable and highly contagious virus would possibly not be short-lived and possibly similar to that caused by other viral infections. “
Previous studies on anti-coronavirus antibodies had indicated that immunity would possibly be short-lived, leaving others vulnerable to reinfection, but the Icelandic study hopes that a vaccine that triggers a strong immune reaction will have a more lasting effect than some thought. .
Icelandic researchers also found that women, non-smokers and older patients had higher levels of antibodies, as did those who had had more serious infections, according to the newspaper.
He keeps going up
On Tuesday, the number of coronavirus cases in the United States exceeded 6. 3 million, and the death toll exceeded 189,000, according to a New York Times count.
According to the same count, the five most sensitive states in coronavirus cases as of Tuesday were: California with more than 742,600; Texas with more than 666,000; Florida with more than 648,000; New York with more than 444,700; Georgia with more than 267,000 inhabitants.
Stopping coronavirus in the rest of the world remains a challenge.
On Tuesday, India outperformed Brazil in the country with the highest number of coronavirus cases in the world, the Post reported. India has added nearly 91,000 cases in the past 24 hours, a new global pandemic record. This pushes the number of cases, in the country beyond 4. 2 million; only the United States recorded more. More than 71,000 people in India have died from COVID-19, making it the most affected country in Asia, the Post reported.
Meanwhile, Brazil recorded 4. 1 million cases and nearly 127,000 deaths on Tuesday, according to the Times count.
Unlike the United States and Brazil, where the number of new instances has fallen in recent weeks, India has reported the largest increases in instances in the world since early August, the Post reported.
After creating the world’s largest blockade this spring, Jayaprakash Muliyil, a prominent Indian epidemiologist, predicted that instances in the country will continue to increase in the coming weeks and told the Post that instances could double over the next month before retiring.
Cases are also expanding in Russia: the number of coronavirus cases in the country exceeded one million, the Times reported. On Tuesday, the death toll in Russia was 17,939.